Svend Andersen to lead Hospira in Europe
pharmafile | October 5, 2010 | Appointment | Manufacturing and Production, Research and Development, Sales and Marketing | Hospira, appointment, manufacturing and production, research and development, sales and marketing
US global specialty pharmaceutical company Hospira has appointed Svend Andersen to lead its operations in Europe with effect from 1 November.
As corporate vice president and president for Europe, Middle East and Africa (EMEA) he will be based in Hospira’s EMEA head offices in Leamington Spa in the UK.
Most recently Svend served as executive vice president for Western Europe at generic specialty pharmaceutical company Actavis, prior to which he was vice president and general manager at Alpharma, a global specialty pharmaceutical company.
Svend will report to Hospira’s chief commercial officer Ron Squarer, who said: “In his more than 20 years in the healthcare industry, he has compiled a strong track record of introducing new products, developing markets and building teams, all of which will be essential as Hospira takes on new opportunities and grows its current business in the EMEA.”
Related Content
Myeloma UK reveals new Director of Research appointment
UK non-profit organisation Myeloma UK has selected Sarah McDonald as its new Director of Research, …
Abbott CEO to step down after 21 years
After more than two decades at the head of the company, it has emerged that …
Lonza CEO to step down in 2020
It has been announced that Marc Funk, Chief Executive Officer at Lonza, is set to …